Meet With Us in 2023

March 12-14, 2023 –  Pacific Society for Reproductive Medicine (PSRM) – Sydney, Australia – PSRM

March 22-26, 2023 – Pacific Coast Reproductive Society (PCRS) – Indian Wells, CA  – PCRS

June 7-10, 2023 – Midwest Reproductive Symposium International (MRSI) – Chicago, IL – MRSI

June 25-28, 2023 – European Society of Human Reproduction and Embryology (ESHRE) – Copenhagen, Denmark – ESHRE

October 14-18, 2023 – American Society for Reproductive Medicine (ASRM) – New Orleans, LA –  ASRM


March 31, 2022 – Women’s Health Campaign with Media Planet USA Future of Personal Health

December 28, 2021 – Future of Fertility/Family at Home Campaign with Media Planet USA An Expert Explains Endometriosis

October 23, 2021 – Fertility Rally

September 2021 – Maternal Health Campaign with Media Planet USA – When Contemplating IVF, Educate and Advocate

March 2021 – Future of Fertility Campaign with Media Planet USA – Future of Fertility

The ReceptivaDxTM Test was developed by Cicero Diagnostics in conjunction with Pathology Consultants, Inc. of Greenville, SC. Pathology Consultants, Inc. is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies. Data have not been submitted to or evaluated by Federal regulatory agencies and the test is not for sale as an In Vitro Diagnostic (IVD) in the US or the EU.

Copyright © 2023 ReceptivaDx™ | All Rights Reserved

Privacy Policy | Terms of Service | Disclaimer